Netherlands· NL-1469d2b506f0
Nipruss 60 mg, poeder voor oplossing voor infusie
A nitroprusside product containing nitroprussidedinatrium 2-water, registered in Netherlands by Altamedics GmbH. The same ATC class is registered in 8 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Nitroprusside is registered in 8 of 19 countries.
Countries holding a registration under ATC C02DD01 (nitroprusside), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 5 of them publish a price we can compare per daily dose
Nitroprusside · ATC C02DD01
8 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Norwayprice
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- NITROPRUSSIDEDINATRIUM 2-WATER
- Manufacturer
- Altamedics GmbH
- Country
- Netherlands (NL)
- ATC code
- C02DD01
- ATC class
- Nitroprusside
- Defined daily dose
- 50 mg, P
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id123483
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
89 interactions on record for nitroprusside.
Graded by severity as the source publishes them — 89 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Nitroprusside · interactions on record
89 records
- 89 moderate
Most severe, free to view
- LidocainA01AE01moderate
- TetracainA01AE02moderate
- ThiethylperazinA04AB03moderate
- DiphenhydraminA04AB05moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under C02DD01
Nitroprusside, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8fb013f1-8135-46c3-a23b-84b716dcaa5f GET /v1/drugs/8fb013f1-8135-46c3-a23b-84b716dcaa5f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Poeder voor oplossing voor infusie",
"route": "Intraveneus gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h123483_smpc.pdf",
"strength": null,
"atc_label": "Nitroprusside",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg123483",
"excipients": [
"GEEN HULPSTOFFEN"
],
"substances": [
"NITROPRUSSIDEDINATRIUM 2-WATER"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h123483.pdf",
"authorised_at": "2020/06/11",
"procedure_number": "DE/H/5521/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "123483",
"additional_monitoring": "N"
}See everything about nitroprusside.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.